AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32331064 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg SPN-812
Number of subjects: 477
Study 32331064 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 477
Study 33586178 — intervention group
Group type: EXPERIMENTAL
Intervention: Online psychoeducational stress management program
Number of subjects: 60
Study 33586178 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 36244384 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqueous 10% povidone‐iodine
Number of subjects: 1638
Study 36244384 — intervention group
Group type: COMPARATOR
Intervention: Aqueous 4% chlorhexidine gluconate
Number of subjects: 1638
Study 34499788 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoral mask
Number of subjects: 36
Study 34499788 — intervention group
Group type: COMPARATOR
Intervention: Classic face mask
Number of subjects: 36
Study 32839843 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab treatment
Number of subjects: 0
Study 35780115 — intervention group
Group type: EXPERIMENTAL
Intervention: eModule (interactive learning activity)
Number of subjects: 32
Study 35780115 — intervention group
Group type: COMPARATOR
Intervention: Wikipedia-like page (non-interactive learning activity)
Number of subjects: 32
Study 35780115 — intervention group
Group type: EXPERIMENTAL
Intervention: eModule
Number of subjects: 32
Study 35780115 — intervention group
Group type: COMPARATOR
Intervention: Wikipedia-like page
Number of subjects: 32
Study 33836772 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass Screening and Treatment (MST) intervention
Number of subjects: 1551
Study 36093566 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 μg selenium as selenium-enriched yeast daily
Number of subjects: 481
Study 36093566 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 μg selenium as selenium-enriched yeast daily
Number of subjects: 481
Study 36093566 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 μg selenium as selenium-enriched yeast daily
Number of subjects: 481
Study 36093566 — intervention group
Group type: EXPERIMENTAL
Intervention: 100, 200, or 300 μg selenium as selenium-enriched yeast daily
Number of subjects: 481
Study 33609973 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (AC) in high-risk patients (34.4%, n = 166)
Number of subjects: 1040
Study 33609973 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (AC) in low-risk patients (36.5%, n = 203)
Number of subjects: 1040
Study 33609973 — intervention group
Group type: COMPARATOR
Intervention: High-risk stage II AA
Number of subjects: 1040
Study 32244970 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Conference Call (CBCC)
Number of subjects: 219
Study 32244970 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral-Activation Conference Call (BACC)
Number of subjects: 219
Study 32244970 — intervention group
Group type: COMPARATOR
Intervention: Usual Care Control Group (CG)
Number of subjects: 219
Study 32244970 — intervention group
Group type: EXPERIMENTAL
Intervention: BACC
Number of subjects: 219
Study 32244970 — intervention group
Group type: EXPERIMENTAL
Intervention: CBCC
Number of subjects: 219
Study 32244970 — intervention group
Group type: EXPERIMENTAL
Intervention: CBCC vs BACC
Number of subjects: 219
Study 36145126 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vitamin B1 and mecobalamin, artificial tears
Number of subjects: 199
Study 36145126 — intervention group
Group type: COMPARATOR
Intervention: Artificial tears
Number of subjects: 199
Study 33351971 — intervention group
Group type: EXPERIMENTAL
Intervention: HTL0018318 (1–35 mg)
Number of subjects: 97
Study 33351971 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 35658869 — intervention group
Group type: EXPERIMENTAL
Intervention: 5R Shared Leadership Program (5RS) in addition to regular group walking
Number of subjects: 503
Study 35658869 — intervention group
Group type: COMPARATOR
Intervention: Regular group walking program
Number of subjects: 503
Study 32275025 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-dexmedetomidine continuous infusion
Number of subjects: 60
Study 32275025 — intervention group
Group type: COMPARATOR
Intervention: Propofol continuous infusion
Number of subjects: 60
Study 35758017 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (NaHCO3) 0.3 g/kg body mass
Number of subjects: 10
Study 35758017 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 33577276 — intervention group
Group type: EXPERIMENTAL
Intervention: C-loop IOL (CT LUCIA 611P)
Number of subjects: 50
Study 33577276 — intervention group
Group type: COMPARATOR
Intervention: 4-point haptic IOL (CT ASPHINA 409MP)
Number of subjects: 50
Study 35483028 — intervention group
Group type: EXPERIMENTAL
Intervention: Trans-radial approach (TRA)
Number of subjects: 20122
Study 33848462 — intervention group
Group type: EXPERIMENTAL
Intervention: Copanlisib plus rituximab
Number of subjects: 458
Study 33848462 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus rituximab
Number of subjects: 458
Study 35013506 — intervention group
Group type: EXPERIMENTAL
Intervention: brief motivational intervention (bMI)
Number of subjects: 88
Study 35013506 — intervention group
Group type: COMPARATOR
Intervention: breastfeeding education (control)
Number of subjects: 88
Study 33713629 — intervention group
Group type: COMPARATOR
Intervention: Theoretical training (Group A)
Number of subjects: 42
Study 33713629 — intervention group
Group type: EXPERIMENTAL
Intervention: Theoretical and practical training (Group B)
Number of subjects: 42
Study 33713629 — intervention group
Group type: EXPERIMENTAL
Intervention: Theoretical and practical training (Group C)
Number of subjects: 42
Study 33713629 — intervention group
Group type: COMPARATOR
Intervention: All groups (A, B, C)
Number of subjects: 42
Study 34980562 — intervention group
Group type: EXPERIMENTAL
Intervention: Health literacy-based group education and phone counseling for 12 weeks
Number of subjects: 120
Study 34980562 — intervention group
Group type: COMPARATOR
Intervention: Routine diabetic care
Number of subjects: 120
Study 33677935 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes Fibrosis Score (DFS)
Number of subjects: 766
Study 33677935 — intervention group
Group type: COMPARATOR
Intervention: Conventional fibrosis scores (NFS, FIB-4, APRI)
Number of subjects: 766
Study 35082320 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous quality improvement interventions (CQI) for prevention of mother-to-child transmission (PMTCT) of HIV
Number of subjects: 0
Study 36069840 — intervention group
Group type: EXPERIMENTAL
Intervention: PA-first group (4-week PA intervention followed by 4-week FVC intervention)
Number of subjects: 552
Study 36069840 — intervention group
Group type: EXPERIMENTAL
Intervention: FVC-first group (4-week FVC intervention followed by 4-week PA intervention)
Number of subjects: 552
Study 36069840 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention groups (PA-first and FVC-first)
Number of subjects: 552
Study 36069840 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in PA self-efficacy and FVC intention
Number of subjects: 552
Study 36069840 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in FVC intention
Number of subjects: 552
Study 36069840 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 552
Study 32359348 — intervention group
Group type: EXPERIMENTAL
Intervention: Butorphanol at the ED95 dose (9.07 μg/kg)
Number of subjects: 200
Study 32359348 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil at the ED95 dose (0.1 μg/kg)
Number of subjects: 200
Study 32359348 — intervention group
Group type: EXPERIMENTAL
Intervention: Both butorphanol and sufentanil
Number of subjects: 200
Study 35230488 — intervention group
Group type: EXPERIMENTAL
Intervention: delgocitinib ointment 30 mg/g (n = 20)
Number of subjects: 31
Study 35230488 — intervention group
Group type: COMPARATOR
Intervention: vehicle ointment (n = 11)
Number of subjects: 31
Study 33352007 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program combined with manual therapy (mobilization group)
Number of subjects: 42
Study 33352007 — intervention group
Group type: COMPARATOR
Intervention: Exercise therapy only (control group)
Number of subjects: 42
Study 36470985 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat Grafting (FG)
Number of subjects: 15
Study 36470985 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic Acid (HA)
Number of subjects: 15
Study 33528537 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile Stroke Unit (MSU) dispatched (n=749)
Number of subjects: 1543
Study 33528537 — intervention group
Group type: COMPARATOR
Intervention: Conventional ambulance only (n=794)
Number of subjects: 1543
Study 33528537 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile Stroke Unit (MSU) dispatched
Number of subjects: 1543
Study 33528537 — intervention group
Group type: COMPARATOR
Intervention: Conventional ambulance only
Number of subjects: 1543
Study 32211417 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyapatite‐coated abutment with soft tissue preservation surgery
Number of subjects: 103
Study 32211417 — intervention group
Group type: COMPARATOR
Intervention: Titanium abutment with soft tissue reduction surgery (control)
Number of subjects: 103
Study 35690093 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% dextrose injection
Number of subjects: 40
Study 35690093 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (0.9% sodium chloride) injection
Number of subjects: 40
Study 36096948 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex regional advance care planning (ACP) intervention
Number of subjects: 3840
Study 36096948 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (Control)
Number of subjects: 3840
Study 35918728 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium supplementation
Number of subjects: 64
Study 35918728 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 34444872 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic resistance interval training plus nutritional intervention
Number of subjects: 34
Study 34444872 — intervention group
Group type: COMPARATOR
Intervention: Nutritional intervention (Control)
Number of subjects: 34
Study 32768682 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Stop Light Diet (eSLD) with behavioral counseling and increased physical activity delivered individually at home
Number of subjects: 128
Study 32768682 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Stop Light Diet (eSLD) with behavioral counseling and increased physical activity delivered to groups via video conferencing
Number of subjects: 128
Study 36123185 — intervention group
Group type: EXPERIMENTAL
Intervention: Drilling guide group (digitally fabricated drilling guide using intraoral scan, CAD, and 3D printing)
Number of subjects: 24
Study 36123185 — intervention group
Group type: COMPARATOR
Intervention: Freehand group (screw channel preparation based on panoramic radiographs without a drilling guide)
Number of subjects: 24
Study 35124916 — intervention group
Group type: EXPERIMENTAL
Intervention: Distance learning IMCI training
Number of subjects: 4
Study 35124916 — intervention group
Group type: COMPARATOR
Intervention: Standard IMCI training (Control)
Number of subjects: 4
Study 36195602 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant treatment
Number of subjects: 0
Study 36195602 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectancy effects
Number of subjects: 0
Study 36195602 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroimaging
Number of subjects: 0
Study 34045114 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive transfusion policy (packed cells when Hemoglobin < 8 g/dL)
Number of subjects: 80
Study 34045114 — intervention group
Group type: COMPARATOR
Intervention: Liberal transfusion policy (packed cells when Hemoglobin < 10 g/dL)
Number of subjects: 80
Study 34045114 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive transfusion policy
Number of subjects: 80
Study 34045114 — intervention group
Group type: COMPARATOR
Intervention: Liberal transfusion policy
Number of subjects: 80
Study 33104004 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic Acupuncture Shoes (EAS)
Number of subjects: 83
Study 33104004 — intervention group
Group type: COMPARATOR
Intervention: Sham EAS plus NSAIDs (Control)
Number of subjects: 83
Study 35938263 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week hatha yoga intervention
Number of subjects: 7
Study 33547949 — intervention group
Group type: EXPERIMENTAL
Intervention: UTMD + XRT
Number of subjects: 24
Study 33547949 — intervention group
Group type: COMPARATOR
Intervention: XRT
Number of subjects: 24
Study 35101644 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 995
Study 33887449 — intervention group
Group type: EXPERIMENTAL
Intervention: Visualization group (image-guided technique)
Number of subjects: 80
Study 33887449 — intervention group
Group type: COMPARATOR
Intervention: Standard group (standard approach)
Number of subjects: 80
Study 35413602 — intervention group
Group type: EXPERIMENTAL
Intervention: Pequi oil nanoencapsulated gel (PeONC)
Number of subjects: 0
Study 33814235 — intervention group
Group type: EXPERIMENTAL
Intervention: Men with overweight or obesity
Number of subjects: 2554
Study 33814235 — intervention group
Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 2554
Study 33814235 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese subjects
Number of subjects: 2554
Study 33814235 — intervention group
Group type: EXPERIMENTAL
Intervention: Overweight subjects
Number of subjects: 2554
Study 33814235 — intervention group
Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 2554
Study 35749267 — intervention group
Group type: EXPERIMENTAL
Intervention: MAX intervention (problem-solving therapy with energy conservation education)
Number of subjects: 41
Study 35749267 — intervention group
Group type: COMPARATOR
Intervention: HE intervention (health education including diet, exercise, and energy conservation education)
Number of subjects: 41
Study 35354828 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk scoring system for progression to severe pneumonia
Number of subjects: 561
Study 34719406 — intervention group
Group type: EXPERIMENTAL
Intervention: Family presence during the weaning process from mechanical ventilation
Number of subjects: 70
Study 34719406 — intervention group
Group type: COMPARATOR
Intervention: Control group (no family presence)
Number of subjects: 70
Study 33415866 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion therapy (once daily for 14 days)
Number of subjects: 95
Study 33415866 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion therapy
Number of subjects: 95
Study 33415866 — intervention group
Group type: COMPARATOR
Intervention: Basic treatment (western medicine)
Number of subjects: 95
Study 34954870 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital informed consent (DIC) using hyperrealistic simulation on a tablet device
Number of subjects: 84
Study 34954870 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hyperrealistic simulation)
Number of subjects: 84
Study 34954870 — intervention group
Group type: EXPERIMENTAL
Intervention: DIC group (subgroup analysis for low education levels)
Number of subjects: 84
Study 34954870 — intervention group
Group type: EXPERIMENTAL
Intervention: DIC group (subgroup analysis for higher education levels)
Number of subjects: 84
Study 33185144 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid Convergent
Number of subjects: 153
Study 33185144 — intervention group
Group type: COMPARATOR
Intervention: CA
Number of subjects: 153
Study 36167477 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.375% 30 mL on each side
Number of subjects: 69
Study 36167477 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (placebo)
Number of subjects: 69
Study 33393805 — intervention group
Group type: EXPERIMENTAL
Intervention: Strategic supports at encoding, monitoring, and cue detection (implementation intentions, visualization, content-free cuing, auditory alarm)
Number of subjects: 116
Study 33393805 — intervention group
Group type: EXPERIMENTAL
Intervention: Cue detection and combination conditions
Number of subjects: 116
Study 33393805 — intervention group
Group type: EXPERIMENTAL
Intervention: Supported PM accuracy in the laboratory
Number of subjects: 116
Study 33393805 — intervention group
Group type: COMPARATOR
Intervention: Unsupported control condition
Number of subjects: 116
Study 33393805 — intervention group
Group type: COMPARATOR
Intervention: Seronegative participants (unsupported control group)
Number of subjects: 116
Study 36145227 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt-reduced bread alone (Intervention A)
Number of subjects: 309
Study 36145227 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt-reduced bread with dietary counselling (Intervention B)
Number of subjects: 309
Study 36145227 — intervention group
Group type: COMPARATOR
Intervention: Control (regular salt content bread)
Number of subjects: 309
Study 34350865 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 47
Study 34350865 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone
Number of subjects: 47
Study 33670720 — intervention group
Group type: EXPERIMENTAL
Intervention: Eggs enriched with ALA, DHA, RmA, and PunA
Number of subjects: 24
Study 33670720 — intervention group
Group type: COMPARATOR
Intervention: Eggs enriched with oleic acid (control group)
Number of subjects: 24
Study 33243334 — intervention group
Group type: EXPERIMENTAL
Intervention: FIo₂ of 0.21 (normoxic)
Number of subjects: 16
Study 33243334 — intervention group
Group type: COMPARATOR
Intervention: FIo₂ of 0.15 (hypoxic)
Number of subjects: 16
Study 33593702 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic contrast-enhanced MRI and diffusion-weighted imaging after two cycles of NAC
Number of subjects: 87
Study 33593702 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model based on MRI parameters
Number of subjects: 87
Study 33215768 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam dressing
Number of subjects: 88
Study 33215768 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocolloid dressing
Number of subjects: 88
Study 36207643 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol administered through a target-controlled infusion device programmed with the covariates model, plasma target concentrations between 2 and 5 μg.mL−1.
Number of subjects: 29
Study 34533825 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 opioid pills (Group 1)
Number of subjects: 60
Study 34533825 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 opioid pills (Group 2)
Number of subjects: 60
Study 32609075 — intervention group
Group type: EXPERIMENTAL
Intervention: Botrytis prunorum isolates
Number of subjects: 3
Study 32609075 — intervention group
Group type: EXPERIMENTAL
Intervention: Boscalid
Number of subjects: 3
Study 32609075 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyprodinil/fludioxonil mixture
Number of subjects: 3
Study 32609075 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenhexamid
Number of subjects: 3
Study 36055294 — intervention group
Group type: EXPERIMENTAL
Intervention: Community mobilisation intervention
Number of subjects: 38400
Study 36055294 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 38400
Study 33851991 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery with plate fixation (n = 38)
Number of subjects: 82
Study 33851991 — intervention group
Group type: COMPARATOR
Intervention: Functional bracing (n = 44)
Number of subjects: 82
Study 33851991 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary surgery group (n = 14)
Number of subjects: 82
Study 35642498 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioactive glass granules
Number of subjects: 49
Study 35642498 — intervention group
Group type: COMPARATOR
Intervention: Standard bone grafts (autologous and allogeneic)
Number of subjects: 49
Study 33039944 — intervention group
Group type: COMPARATOR
Intervention: Ocrelizumab 600 mg administered over 3.5 hours (conventional duration)
Number of subjects: 745
Study 33039944 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocrelizumab 600 mg administered over 2 hours (shorter duration)
Number of subjects: 745
Study 612819042 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient pain education programs (PEPs)
Number of subjects: 54
Study 612819042 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 54
Study 612819042 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioids
Number of subjects: 54
Study 33963479 — intervention group
Group type: EXPERIMENTAL
Intervention: β ‐glucan (200 mg daily)
Number of subjects: 138
Study 33963479 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study 33675850 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (25 mg weekly oral)
Number of subjects: 216
Study 33675850 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate Mofetil (1.5 g twice daily oral)
Number of subjects: 216
Study 32169380 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal allergen challenge (NAC)
Number of subjects: 24
Study 32169380 — intervention group
Group type: COMPARATOR
Intervention: Environmental exposure chamber (EEC)
Number of subjects: 24
Study 35230140 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal cocktail
Number of subjects: 100
Study 35230140 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine plus patient‐controlled analgesia
Number of subjects: 100
Study 32050234 — intervention group
Group type: EXPERIMENTAL
Intervention: Small incision lenticule extraction (SMILE)
Number of subjects: 60
Study 32050234 — intervention group
Group type: COMPARATOR
Intervention: Femtosecond laser‐assisted laser in situ keratomileusis (FS‐LASIK)
Number of subjects: 60
Study 36480788 — intervention group
Group type: EXPERIMENTAL
Intervention: No Pain III™ computer-controlled local anesthesia delivery (CCLAD) system
Number of subjects: 30
Study 36480788 — intervention group
Group type: COMPARATOR
Intervention: Conventional syringe
Number of subjects: 30
Study 32651955 — intervention group
Group type: EXPERIMENTAL
Intervention: PT20 (400, 800, 1600 or 3200 mg)
Number of subjects: 153
Study 32651955 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153
Study 32651955 — intervention group
Group type: EXPERIMENTAL
Intervention: PT20
Number of subjects: 153
Study 32245696 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine (60 mg/day)
Number of subjects: 353
Study 32093617 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan (4 mg)
Number of subjects: 34